This trial is active, not recruiting.

Condition osteoarthritis of the knee
Treatment calcium phosphate macroporous bioceramics
Sponsor Nantes University Hospital
Start date May 1999
Trial size 50 participants
Trial identifier NCT00200603, BRD/99/3-G


The aim of the study is to compare radiological behavior of blocks of macroporous phosphocalcium as bone substitute in comparison with iliac crest autograft in tibial valgus osteotomy.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Allocation randomized
Intervention model parallel assignment
Masking open label
Primary purpose treatment

Primary Outcomes

Radiological healing and stability of the osteotomy measure at 3, 6, 12 and 24 months after surgery
time frame:

Secondary Outcomes

Knee and iliac crest painSurgical complicationsFonctional results
time frame:

Eligibility Criteria

Male or female participants from 18 years up to 75 years old.

Inclusion Criteria: - knee osteoarthritis eligible for tibial valgus osteotomy - > 18 y.o Exclusion Criteria: - prior tibial osteotomy - history of local infection - rheumatoid and other inflammatory arthritis

Additional Information

Official title Autograft Versus Calcium Phosphate Macroporous Bioceramics as Bone Substitute for Tibial Valgus Osteotomy
Principal investigator François Gouin, MD
Trial information was received from ClinicalTrials.gov and was last updated in December 2005.
Information provided to ClinicalTrials.gov by Nantes University Hospital.